Carolyn Harris

A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).

A. Dear, A. Chronopoulos, C. Gilfillan, 2022, Journal of diabetes and its complications.

TRPV2 suppresses Rac1 and RhoA activation and invasion in rheumatoid arthritis fibroblast‐like synoviocytes

P. Gulko, T. Laragione, Carolyn Harris, 2019, International immunopharmacology.

Intestinal epithelial Notch-1 protects from colorectal mucinous adenocarcinoma

A. Iuga, Jean-Vianney Haure-Mirande, S. Dahan, 2018, Oncotarget.

Magnesium increases numbers of Foxp3+ Treg cells and reduces arthritis severity and joint damage in an IL-10-dependent manner mediated by the intestinal microbiome

P. Gulko, G. Bongers, C. Beeton, 2023, EBioMedicine.

Combination therapy of a TRPV2 agonist with a TNF inhibitor achieves sustained suppression of disease severity and reduced joint damage

P. Gulko, T. Laragione, Carolyn Harris, 2022, Clinical and experimental immunology.

Huntingtin-interacting protein 1 (HIP1) regulates arthritis severity and synovial fibroblast invasiveness by altering PDGFR and Rac1 signalling

P. Gulko, M. Brenner, A. Lahiri, 2018, Annals of the rheumatic diseases.

Gene Network Analyses Identify Co-regulated Transcription Factors and BACH1 as a Key Driver in Rheumatoid Arthritis Fibroblast-like Synoviocytes

P. Gulko, Aurélien Pélissier, T. Laragione, 2024, bioRxiv.

KIF1C and new Huntingtin-interacting protein 1 binding proteins regulate rheumatoid arthritis fibroblast-like synoviocytes’ phenotypes

P. Gulko, T. Laragione, Carolyn Harris, 2024, Frontiers in immunology.